1. Assessment of Ventricular Repolarization Variability with the DeltaT50 Method Improves Identification of Patients with Congenital Long QT Syndromes. Issue 3 (22nd November 2012) Authors: Abrahamsson, Christina; Dota, Corina; Skallefell, Bo; Carlsson, Leif; Frison, Lars; Berggren, Anders; Edvardsson, Nils; Duker, Göran Journal: Annals of noninvasive electrocardiology Issue: Volume 18:Issue 3(2013:May) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. Issue 11 (10th June 2022) Authors: Rekić, Dinko; Azarov, Ivan; Knöchel, Jane; Sokolov, Victor; Nilsson, Catarina; Wernevik, Linda; Han, David; Rydén‐Bergsten, Tina; Ebrahimi, Ahmad; Dota, Corina; Carlsson, Björn Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 11(2022) Page Start: 4839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Can Bias Evaluation Provide Protection Against False‐Negative Results in QT Studies Without a Positive Control Using Exposure‐Response Analysis?. (7th July 2016) Authors: Ferber, Georg; Zhou, Meijian; Dota, Corina; Garnett, Christine; Keirns, James; Malik, Marek; Stockbridge, Norman; Darpo, Borje Journal: Journal of clinical pharmacology Issue: Volume 57:Number 1(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Concentration‐QT modelling in early clinical oncology settings: Simulation evaluation of performance. Issue 3 (9th September 2021) Authors: Cantet, Gael; Berges, Alienor; O'Sullivan, Rhianna; Cohen‐Rabbie, Sarit; Dota, Corina; Dubois, Vincent; Benoist, Guillemette E.; Tomkinson, Helen; Rekić, Dinko; Parkinson, Joanna; Schalkwijk, Stein Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 3(2022) Page Start: 1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations. Issue 2 (28th September 2021) Authors: Voronova, Veronika; Cullberg, Marie; Delff, Philip; Parkinson, Joanna; Dota, Corina; Schiavon, Gaia; Maroj, Brijesh; Rekić, Dinko; Cheung, S. Y. Amy Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 2(2022) Page Start: 858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small‐Molecule New Drug Applications Approved During 2011‐2019. (12th April 2021) Authors: Cohen‐Rabbie, Sarit; Berges, Alienor C.; Rekić, Dinko; Parkinson, Joanna; Dota, Corina; Tomkinson, Helen K. Journal: Journal of clinical pharmacology Issue: Volume 61:Number 8(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The IQ‐CSRC Prospective Clinical Phase 1 Study: "Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?". Issue 1 (30th December 2013) Authors: Darpo, Borje; Sarapa, Nenad; Garnett, Christine; Benson, Charles; Dota, Corina; Ferber, Georg; Jarugula, Venkateswar; Johannesen, Lars; Keirns, James; Krudys, Kevin; Ortemann‐Renon, Catherine; Riley, Steve; Rogers‐Subramaniam, Danise; Stockbridge, Norman Journal: Annals of noninvasive electrocardiology Issue: Volume 19:Issue 1(2014:Jan.) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Issue 2 (24th September 2020) Authors: Vargas, Hugo M.; Rolf, Michael G.; Wisialowski, Todd A.; Achanzar, William; Bahinski, Anthony; Bass, Alan; Benson, Charles T; Chaudhary, Khuram W.; Couvreur, Nicolas; Dota, Corina; Engwall, Michael J; Michael Foley, C.; Gallacher, David; Greiter‐Wilke, Andrea; Guillon, Jean‐Michel; Guth, Brian; H... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 2(2021) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗